Close Menu

Nobel Prize-winning scientist Paul Greengard has discovered a new way for researchers to target Alzheimer's disease. Beta amyloid, the plaque that builds up in the brains of Alzheimer's patients, has long been targeted by researchers. Now Greengard has discovered a new protein that is needed to make beta amyloid, reports the New York Times' Gina Kolata. Many Alzheimer's drugs currently being studied target the enzyme gamma secretase, which helps make beta amyloid.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.